Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BALMYS-19: Adipose MSCs for COVID-19 ARDS
NCT04348461Phase 2Suspended
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- May 2020
- Primary completion
- Sep 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic adipose tissue-derived mesenchymal stromal cells in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Started May 2020; status: suspended.
02
Drugs
allogeneic adipose tissue-derived mesenchymal stromal cells
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04348461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04348461.